Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.
about
Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progenyCancer Stem Cells in Human Gastrointestinal CancerEmerging therapeutic targets in esophageal adenocarcinomaEsophageal cancer stem cells and implications for future therapeuticsMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersThe hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironmentTRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell populationOncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.New promising drug targets in cancer- and metastasis-initiating cells.The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrenceCancer stem cells: the final frontier for glioma virotherapy.Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancersWISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice.Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression.Reprogramming mediated radio-resistance of 3D-grown cancer cells.Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cellsOncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Relationship of Oct-4 to malignant stage: a meta-analysis based on 502 positive/high Oct-4 cases and 522 negative/low case-free controls.Therapeutic strategies targeting cancer stem cellsOncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cellsTargeting cancer stem cells with oncolytic virusRecent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications.Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer.Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation.Over-expression of Oct4 in human esophageal squamous cell carcinomaAltered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.New perspectives in cancer virotherapy: bringing the immune system into play.Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges.Isogenic radiation resistant cell lines: development and validation strategies.Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms.
P2860
Q21245485-B2A04B6C-31E0-4ACB-9956-576637AC058DQ26737714-F96FD397-7EFD-4913-920D-BD7AD99415FEQ26751209-5FAB533C-E583-4BBD-B75D-C978F4160742Q26752943-E72803A3-F723-4172-9CBA-51D698D67682Q26822406-5EA90B6A-1144-40F4-9C53-9EA08E366B6AQ28728396-B78FF493-D0C5-4996-BA2D-37383BF6D70DQ33743051-1A2B4B4B-45BD-4980-9AA1-62F4524BD010Q33906116-A006275E-84BC-4E08-BA99-AE29F3FFCDC5Q34003691-F7BAB2A8-C26A-478A-A082-895D79B0D62CQ34323827-8FCF7C97-3911-41DE-8C14-E793FF3FAD1DQ34382586-1DFCA34B-5AE5-497D-A363-DEF99EA2645FQ34382914-A44F36E4-6470-4F6E-80EC-86EE001A0EFFQ34516701-8C0D3FFA-411E-414D-9489-EC8F8F437294Q34778345-BC6BFB38-3EF3-4A70-9A8C-2440A1E3FF7DQ34985594-7AAF85CA-ECD5-472E-AC36-BACF400EF2E9Q35146725-857EE211-2F22-47B7-A3F8-5EA1DFB657CFQ35571898-71F623B2-CD91-4556-B651-CE06981C61FDQ35659029-D8ECB7BA-124D-42D6-ABB8-23E278296F68Q35835116-4B139931-EFA5-4376-BC24-B3B3B8026328Q35835166-4DB4EF70-2ADC-42D7-A70F-7BCC8A10F498Q36286110-3FE7861B-C478-4403-9257-D3CD9CA236E5Q36346959-9ABC3067-6DF4-48EF-B710-C60C51C7003DQ36634430-C41218F0-2DDC-4F6E-AAC4-3BBA34CFD7CDQ36739064-60D55089-BD4B-4786-87CC-22EBF9D9DDD6Q36887716-BAF0ADA5-D274-45A8-A8B8-E68F37F0AC9CQ37007756-6D8DCCC6-54BA-4E38-B6A7-67AB58CDB825Q37044088-0093C6F8-9E66-45EB-A2F7-A6ED1CD1D6AFQ37310063-BD4454FC-19EB-4641-8C75-E79D6877CBD1Q37353493-0DB7C879-8028-4FAF-A40D-435600384DB2Q37440963-4186B1EC-FFCB-40A5-91FD-B8F80B402602Q37461213-630C9742-A4F2-44D2-9948-AF333460B270Q37610799-F4697C87-7F3E-4A28-BFC5-26A4A04A7FD4Q37629613-AFE06BA9-0C66-4F65-AB2A-339F754F36CDQ37773253-B4366817-972A-4D6C-87AD-723272CC3E8CQ37920789-192921AB-EFAA-4213-B260-8BD7F3159E5BQ38172298-FFBE45AB-686C-462F-B1B1-C67C30C36E22Q38922855-5D2D855A-B086-4BF3-B182-0D1D47782685Q39066150-A85CCAC8-0685-4CF5-8DFA-C6EA640327F2Q42131289-146C0096-8A6F-47C6-909E-8D4D5E772D17Q52718361-69891DC4-36D4-4D04-BB13-D6A96AE77377
P2860
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@ast
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@en
type
label
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@ast
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@en
prefLabel
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@ast
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@en
P2093
P2860
P921
P1476
Treatment of radioresistant st ...... specific oncolytic adenovirus.
@en
P2093
Bingliang Fang
Joe Y Chang
Xiaochun Zhang
P2860
P304
P356
10.1158/1078-0432.CCR-07-1528
P407
P577
2008-05-01T00:00:00Z